Annales de cardiologie et d'angeiologie最新文献

{"title":"Le scanner pré-ablation de fibrillation auriculaire est une opportunité pour dépister la maladie coronaire","authors":"Adrien Pasteur-Rousseau ,&nbsp;Karam Souibri ,&nbsp;Fabien Vannier ,&nbsp;Benjamin Schurr ,&nbsp;Laurent Sebagh ,&nbsp;Guillaume Abehsira","doi":"10.1016/j.ancard.2025.101939","DOIUrl":"10.1016/j.ancard.2025.101939","url":null,"abstract":"<div><div>Atrial fibrillation is a frequent and potentially severe cardiovascular disease. Pulmonary vein isolation by radiofrequency is a common and increasing treatment. Pre-ablation cardiac CT-scan allows the screening for anomalous pulmonary venous return or for thrombus in the left atrial appendage. Moreover, it permits a complete three-dimensional left atrial mapping before the ablation, complementary to the electric mapping. But this acquisition also allows coronary artery analysis if the heart rhythm is controlled. The visualization of the coronary arteries permits the detection of obstructive coronary disease leading to revascularisation, thus lowering the anaesthesia risk during pulmonary vein isolation procedure but also allows the diagnostic of early and moderate stages of coronary atherosclerosis, guiding the preventive therapies thus improving the patient’s outcomes. Coronary analysis should be a constant goal while performing pre-ablation cardiac CT-scan.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 5","pages":"Article 101939"},"PeriodicalIF":0.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145095995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Atteinte cardio-vasculaire dans la maladie d’Erdheim-Chester (MEC) : à propos d’un cas","authors":"I Boussoghi,&nbsp;H. Mhani,&nbsp;B. El Boussaadani,&nbsp;Z. Raissouni","doi":"10.1016/j.ancard.2025.101968","DOIUrl":"10.1016/j.ancard.2025.101968","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Introduction&lt;/h3&gt;&lt;div&gt;La maladie d'Erdheim-Chester (MEC) a été décrite pour la première fois en 1930 par Jakob Erdheim et son élève William Chester. C’est une Forme d’histiocytose non-langerhansienne qui est rare, et d'étiologie indéterminée, caractérisée par une atteinte multi systémique ; osseuses, et plus important des sites extra-osseux à savoir le cœur et les vaisseaux, le poumon, le cerveau, le rétropéritoine, le tissu cutané et rétro-orbitaire, la thyroïde …&lt;/div&gt;&lt;div&gt;Face à cette diversité clinique, Nous rapportons dans cette observation le cas d’un patient avec un tableau clinique riche, avec notamment une mise au point sur l’atteinte cardio-vasculaire.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Description du cas&lt;/h3&gt;&lt;div&gt;Nous rapportons le cas d’un patient âgé de 50 ans, ayant comme facteurs de risque cardio-vasculaires le sexe masculin et un tabagisme chronique à raison de 10 paquets-années, sevré il y a 10 ans, suivi depuis Février 2024 pour Maladie d’Erdheim-Chester, diagnostiquée sur des critères :&lt;/div&gt;&lt;div&gt;Cliniques : Des douleurs osseuses des os longs des membres inférieurs, Une splénomégalie, Une atteinte neurologique a type de syndrome cérébelleux.&lt;/div&gt;&lt;div&gt;Biologiques : Un syndrome inflammatoire biologique&lt;/div&gt;&lt;div&gt;Radiologiques : Atteinte osseuse et extra-osseuse&lt;/div&gt;&lt;div&gt;-Syndrome interstitiel pulmonaire.&lt;/div&gt;&lt;div&gt;-Infiltrat tissulaire péri-rénale et péri-splénique (aspect de reins chevelus avec dilatation calicielle).&lt;/div&gt;&lt;div&gt;- Epaississement péri-aortique s’étendant jusqu’aux artères iliaques primitives&lt;/div&gt;&lt;div&gt;- Présence de multiples condensations osseuses&lt;/div&gt;&lt;div&gt;- Pleurésie bilatérale avec épanchement péricardique&lt;/div&gt;&lt;div&gt;Histologiques: BOM montrant une moelle osseuse avec un infiltrat histiocytaire dont l'aspect morphologique et le profil Immuno-histochimique est en faveur d'une maladie d'Erdheim-chester (CD68 +, Ac anti CD1a-).&lt;/div&gt;&lt;div&gt;Le Tableau clinique s’est aggravé un an après par une Thrombose veineuse cérébrale (TVC) mise sous Sintrom d’aspect stable sur l’imagerie cérébrale de contrôle.&lt;/div&gt;&lt;div&gt;Un mois plus tard, le patient fut hospitalisé au service de cardiologie pour un tableau clinique de syndrome coronarien aigue sans surélévation du segment ST associé à une poussée d’insuffisance cardiaque gauche, avec à l’Echocardiographie une Fraction d’éjection du ventricule gauche conservée, une fuite mitrale grade II et un épanchement péricardique de faible à moyenne abondance et à la coronarographie une sténose de 60% sur l’artère interventriculaire antérieure, avec une lésion de moins de 50% sur l’artère circonflexe.&lt;/div&gt;&lt;div&gt;La radiologie a montré une stabilité des lésions osseuses et extra-osseuses qui existaient auparavant, en attente de compléter l’exploration par une IRM cardiaque pour mieux caractériser l’atteinte cardiaque.&lt;span&gt;&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Histiocytose non langheransienne qui peut être associée à des complications cardiovasculaires aggravant l","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 5","pages":"Article 101968"},"PeriodicalIF":0.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145358196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"REhospitalizations in elderly patients with Advanced Cardiac Telemonitoring: results from the monocentric REACT-HF study","authors":"R. Esser ,&nbsp;M. Larbaneix ,&nbsp;M. Co ,&nbsp;M. Esteban ,&nbsp;J. Corny ,&nbsp;M. Harboun ,&nbsp;N. Pages ,&nbsp;S. Nisse Durgeat ,&nbsp;O. Maurou","doi":"10.1016/j.ancard.2025.101962","DOIUrl":"10.1016/j.ancard.2025.101962","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Introduction&lt;/h3&gt;&lt;div&gt;L’insuffisance cardiaque (IC) est un enjeu majeur de santé publique, associée à une forte morbi-mortalité, en particulier chez les sujets âgés. Depuis juillet 2023, la télésurveillance des patients insuffisants cardiaques est remboursée en France, permettant une diffusion plus large de plateformes numériques comme Satelia® Cardio. Ce dispositif repose sur un système d’alertes automatisées couplé à un suivi infirmier structuré, afin de renforcer la prise en charge en ambulatoire.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;div&gt;Évaluer l’impact de la télésurveillance Satelia® Cardio sur les réhospitalisations liées à l’IC dans l’année suivant une hospitalisation pour décompensation cardiaque chez des patients âgés.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthodes&lt;/h3&gt;&lt;div&gt;Étude observationnelle rétrospective, monocentrique. Tous les patients âgés hospitalisés pour IC à l’Hôpital La Porte Verte et inclus dans le programme Satelia® Cardio entre son lancement et la date d’extraction des données ont été analysés, à condition de disposer d’un suivi de 12 mois. Les patients sans hospitalisation récente ou avec arrêt précoce de la télésurveillance ont été exclus. Le suivi reposait sur un questionnaire hebdomadaire de symptômes et une surveillance du poids, avec génération d’alertes selon un score codé par couleurs déclenchant une intervention médicale.&lt;/div&gt;&lt;div&gt;Le critère principal était la survenue d’une réhospitalisation pour IC dans les 12 mois suivant la sortie. Les critères secondaires incluaient l’identification des facteurs prédictifs de réhospitalisation et la description du profil démographique et clinique des patients.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Résultats&lt;/h3&gt;&lt;div&gt;Entre avril 2023 et avril 2025, 135 patients âgés (âge moyen 85,8 ± 6,8 ans; 53,3 % de femmes) hospitalisés pour IC aiguë ont été inclus. Tous vivaient à domicile avec un bon niveau d’autonomie (ADL moyen: 5,3/6). Le score de comorbidités de Charlson était en moyenne de 7,97 ± 2,3. La dénutrition concernait 42 % des patients, et 26 % présentaient une obésité. Des troubles cognitifs étaient retrouvés chez 5,9 %, et un syndrome dépressif chez 20 %. Les principales comorbidités incluaient l’hypertension (71 %), la fibrillation auriculaire/flutter (79 %), la cardiopathie ischémique (64 %) et une insuffisance rénale chronique avec DFG &lt; 45 ml/min (56 %).&lt;/div&gt;&lt;div&gt;Les carences biologiques étaient fréquentes: vitamine D (64 %), folates (22 %), carence martiale absolue (24 %) et fonctionnelle (23 %). À la sortie, 94 % des patients étaient traités par diurétiques (dose moyenne équivalente furosémide: 113,7 ± 163,1 mg/j) et 76 % par anticoagulants.&lt;/div&gt;&lt;div&gt;À 12 mois, 29 patients (21,5 %) ont été réhospitalisés pour IC. En analyse univariée, les facteurs associés à la réhospitalisation comprenaient: score de Charlson (p=0,046), antécédent de BPCO (p=0,022), dose de diurétiques à la sortie (p=0,037), insuffisance mitrale au moins modérée (p&lt;0,001), et carence martiale vraie (p&lt;0,001).&lt;/div&gt;","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 5","pages":"Article 101962"},"PeriodicalIF":0.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145358197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Myocardial infarction of the elderly : After FIRE trial, complete coronary revascularization for all ?]","authors":"Gabriel Chevrot, Giorgia Piccagliani, Marie Hauguel-Moreau","doi":"10.1016/j.ancard.2025.101919","DOIUrl":"10.1016/j.ancard.2025.101919","url":null,"abstract":"<p><p>Myocardial infarction (MI) is the leading cause of death worldwide, particularly affecting the elderly, a growing population. Yet, their management remains under-researched, especially in cases of multivessel coronary artery disease. These patients are at higher risk for post-procedural complications, but evidence - especially from the FIRE study (2023 - suggests that complete revascularization guided by coronary physiology (FFR or QFR) significantly reduces cardiovascular events in patients over 75, without a significant increase in complications. However, other studies like FLOWER-MI and SENIOR-RITA offer more nuanced perspectives. FLOWER-MI did not show a benefit of FFR guidance in younger patients, while SENIOR-RITA (2024) found that an invasive strategy after a non ST elevation acute coronary syndrome did not improve survival over medical therapy in very comorbid elderly patients, though it did reduce the rate of recurrent MIs. In conclusion, complete physiology-guided revascularization appears beneficial and safe for robust or mildly comorbid elderly patients, whereas a conservative approach may be preferable for more frail individuals. Treatment decisions should be individualized, considering overall health, comorbidities, life expectancy, patient preferences, and ideally discussed within a cardiogeriatric team. There's a growing need for practical tools to assess patient frailty and support clinical decision-making.</p>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 4","pages":"101919"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144811527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Transcatheter aortic valve implantation in women: Sex-specific features].","authors":"Thomas Barbe, Nicolas Bettinger, Attoumane Abdou Cheikh, Hélène Eltchaninoff","doi":"10.1016/j.ancard.2025.101924","DOIUrl":"10.1016/j.ancard.2025.101924","url":null,"abstract":"<p><p>Women remain underrepresented in major TAVI studies, despite notable anatomical, pathophysiological, and clinical characteristics. These differences impact diagnosis, technical decisions, outcomes, and post-TAVI complications. Women typically present with a smaller aortic annulus, lower calcific burden but increased fibrosis, and a specific hemodynamic profile: paradoxical low-flow, low-gradient aortic stenosis. In the short term, they are at higher risk of annular rupture, coronary obstruction, and vascular complications, but experience less paravalvular regurgitation. In the long term, women benefit from better survival and a quality of life comparable to that of men. In light of these findings and the RHEIA study, a sex-specific, personalized approach is essential in the management of aortic stenosis.</p>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 4","pages":"101924"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144811529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Angor réfractaire et place du réducteur de sinus coronaire","authors":"Pierre Bourbon ,&nbsp;Matthieu Périer ,&nbsp;Benamer Hakim","doi":"10.1016/j.ancard.2025.101928","DOIUrl":"10.1016/j.ancard.2025.101928","url":null,"abstract":"<div><div>Refractory angina is characterized by angina-type pain, which remains uncontrolled despite pharmacological optimization, and patients are not eligible or unsuitable for further interventional or surgical revascularisation. This condition may concern 5 to 10 % of coronary artery disease patients. This review gives an overview of the conventional pharmacological and interventional approaches in the field of refractory angina. It considers the variety of emerging non-pharmacological therapeutics and technologies addressing neural pain processing or myocardial perfusion, and offers a special focus on the coronary sinus reducer implantation technique, its physiopathological rationale and its clinical evidence.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 4","pages":"Article 101928"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144864197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La réadaptation cardiaque de la femme coronarienne","authors":"Mohamed Ghannem ,&nbsp;Inès Cazaubiel","doi":"10.1016/j.ancard.2025.101920","DOIUrl":"10.1016/j.ancard.2025.101920","url":null,"abstract":"<div><div>The coronary disease is the leading cause of mortality in women, with 4 to 6 times more deaths than breast cancer. Classically, cardiovascular risk factors show some particularities. Acute coronary syndromes with non-obstructive forms, known as MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries), occur more frequently in women than in men, particularly including coronary spasm, microcirculatory ischemia, spontaneous coronary artery dissections (SCAD), and stress cardiomyopathy (takotsubo). The proven benefits of cardiac rehabilitation on hard endpoints, such as morbidity and mortality, do not prevent it from being underutilized, especially in women. The cardiovascular rehabilitation program must be personalized and adapted.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 4","pages":"Article 101920"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144827035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Revascularisation du patient ponté : revue de la littérature des stratégies thérapeutiques","authors":"Sara Jourani ,&nbsp;Zakariae Laraichi ,&nbsp;Hakim Benamer","doi":"10.1016/j.ancard.2025.101922","DOIUrl":"10.1016/j.ancard.2025.101922","url":null,"abstract":"<div><div>Myocardial ischemia occurring in patients with history of coronary artery bypass grafting (CABG) presents a significant therapeutic challenge. Vein graft degeneration, particularly of saphenous vein grafts, is a common complication with a time-dependent increase in incidence. Although arterial grafts offer greater long-term durability, they are not exempt from complications and may also require percutaneous interventions, which are often technically complex. Through this literature review, we examine the various revascularization strategies and reassess current guidelines, with the aim of optimizing therapeutic management in this high-risk patient population.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 4","pages":"Article 101922"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144864199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Imagerie intracoronaire : quelle place dans la pathologie cardiovasculaire de la femme ?","authors":"Serigne C.T. Ndao,&nbsp;Nicolas Amabile","doi":"10.1016/j.ancard.2025.101916","DOIUrl":"10.1016/j.ancard.2025.101916","url":null,"abstract":"<div><h3>Background</h3><div>Coronary artery disease remains the leading cause of mortality among women, despite a persistent underestimation of its clinical impact. Intracoronary imaging techniques (ICI), such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), have emerged as valuable tools to complement angiography, especially in women, whose pathophysiological mechanisms are often atypical.</div></div><div><h3>Aims</h3><div>To analyse current data on the use of ICI in women and highlight its benefits, limitations, and sex-specific considerations.</div></div><div><h3>Methods</h3><div>Narrative review of recent literature, including observational studies, post-hoc analyses of randomized trials, and registries focusing on IVUS and OCT use in women.</div></div><div><h3>Results</h3><div>Women tend to have smaller coronary arteries, less extensive atherosclerotic disease, and distinct plaque composition, with a predominance of erosions over ruptures. These characteristics are poorly assessed by angiography alone, reinforcing the value of ICI, particularly in cases of MINOCA and spontaneous coronary artery dissection (SCAD). Despite demonstrated clinical benefits, ICI remains underused in women, with lower penetration into routine practice and underrepresentation in clinical trials. Complications related to intracoronary imaging are rare and comparable between genders, if precautions specific to female anatomy are observed.</div></div><div><h3>Conclusion</h3><div>ICI represents a significant yet underutilized opportunity to improve cardiovascular outcomes in women. Better integration of this technology into diagnostic and therapeutic strategies, combined with more gender-specific research, is essential to reduce persistent disparities in care.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 4","pages":"Article 101916"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144889088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Percutaneous treatment of severe tricuspid regurgitation: indications and therapeutic options through two clinical cases].","authors":"Andrei Georgian Florescu, Enrique Alonso, Emilie Fougères, Morad Djebbar, Imane Bagdadi, Antoinette Neylon, Mariama Akodad","doi":"10.1016/j.ancard.2025.101917","DOIUrl":"10.1016/j.ancard.2025.101917","url":null,"abstract":"<p><p>Severe tricuspid regurgitation, considered a benign condition for decades, is now recognized for its significant impact on morbidity, mortality and quality of life. Despite this awareness, management often remains limited to symptomatic treatment with diuretics while surgery is rarely proposed due to a high operative risk approaching 10%. In this context transcatheter therapies have gained considerable momentum and represent a credible therapeutic alternative for high-risk patients. Among the emerging strategies, two techniques are predominant: edge-to-edge repair, the most extensively studied to date and now well established and transcatheter tricuspid valve replacement whose clinical data and visibility are steadily increasing owing to promising results. Therapeutic decision-making relies on a multidisciplinary evaluation incorporating clinical parameters, multimodality imaging and detailed valvular morphology. Two clinical cases are presented to illustrate the key factors guiding indication and procedural strategy for each approach.</p>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 4","pages":"101917"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144811528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}